However, the neurodegenerative demise in ALS is associated with elevated cerebrospinal fluid (CSF) and blood serum neurofilament levels, but this biomarker is not specifically correlated with ALS occurrence such as elevated levels of Tau in various types of dementia and brain injuries.2, 3. The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.